Henry Schein Inc. Common Stock (HSIC)
Stock · NASDAQ · Health Care
$86.38as of 10/16/2026
Price chart
Active signals
No technical signal is currently active for this symbol.
HSIC Signal Track Record
How signals performed across all stocks →What HSIC's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| 200-Day Moving Average Touch | 33 | -0.2% | 48% | May 4, 2026 |
| Volume Spike | 29 | -0.7% | 45% | October 8, 2026 |
| Bollinger Band Breakdown | 24 | +0.4% | 50% | September 10, 2026 |
| Bollinger Band Breakout | 17 | -0.4% | 41% | August 4, 2026 |
| Any 20-session window (baseline) | -0.3% | 49% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About HSIC
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, te…
- Sector
- Health Care
- Industry
- Medical Specialities
- Employees
- 25,000
- Website
- www.henryschein.com/
Fundamentals
- 1-day range
- $83.48$85.09
- Market cap
- $9.83B
- P/E (trailing)
- 23.23
- P/E (forward)
- 14.04
- EPS (trailing)
- $3.43
- Dividend yield
- —
- Beta
- 0.86
- Avg. volume
- 1.22M
How Henry Schein Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 24, 2026 · via SEC EDGAR / Finnhub
Forecasts
15 analyst ratings
Henry Schein Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- HSICHenry Schein Inc. Common Stock$86.38▼ 0.70%Market cap $9.83BP/E 23.23$61.95$92.18
- MOHMolina Healthcare Inc Common Stock$207.36▼ 2.42%Market cap $10.02BP/E 1257.31$121.06$244.89
- OSCROscar Health Inc. Class A Common Stock$31.89▼ 4.72%Market cap $8.00BP/E 18.32$10.69$35.01
- CAICaris Life Sciences Inc. Common Stock$30.56▼ 3.78%Market cap $5.65BP/E 76.07$14.19$33.66
- RDNTRadNet Inc. Common Stock$68.8▼ 2.29%Market cap $5.36BP/E —$50.82$85.84
- CELCCelcuity Inc. Common Stock$56.58▼ 6.17%Market cap $4.55BP/E —$46.51$151.02
- BLLNBillionToOne Inc. Class A Common Stock$98.12▼ 4.49%Market cap $4.22BP/E 128.54$61.96$150.44
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| HSIC Henry Schein Inc. Common Stock | $9.83B | 23.23 | $86.38 | ▼ 0.70% | $61.95$92.18 |
| MOH Molina Healthcare Inc Common Stock | $10.02B | 1257.31 | $207.36 | ▼ 2.42% | $121.06$244.89 |
| OSCR Oscar Health Inc. Class A Common Stock | $8.00B | 18.32 | $31.89 | ▼ 4.72% | $10.69$35.01 |
| CAI Caris Life Sciences Inc. Common Stock | $5.65B | 76.07 | $30.56 | ▼ 3.78% | $14.19$33.66 |
| RDNT RadNet Inc. Common Stock | $5.36B | — | $68.8 | ▼ 2.29% | $50.82$85.84 |
| CELC Celcuity Inc. Common Stock | $4.55B | — | $56.58 | ▼ 6.17% | $46.51$151.02 |
| BLLN BillionToOne Inc. Class A Common Stock | $4.22B | 128.54 | $98.12 | ▼ 4.49% | $61.96$150.44 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Henry Schein appoints Emmanuel Caprais as CFOYahoo · 10/9/2026
- These S&P500 stocks that are showing activity before the opening bell on Thursday.ChartMill · 10/8/2026
- Henry Schein Announces Chief Financial Officer Leadership TransitionYahoo · 10/8/2026
- 3 Low-Volatility Stocks with Open QuestionsYahoo · 10/8/2026
- HSIC or MMSI: Which Is the Better Value Stock Right Now?Yahoo · 10/6/2026
- Should Value Investors Buy Henry Schein (HSIC) Stock?Yahoo · 10/6/2026
- Dental Implants and Prosthetics Market Forecasts Growth from $12.79B (2026) to $17.67B by 2031, Profiling Institut Straumann, Envista, Dentsply Sirona & Henry ScheinYahoo · 10/1/2026
- Cardinal Health: I'm Still Buying After Checking The NumbersSeekingAlpha · 9/30/2026
Insider Activity
Insider Actions →- Andrea Albertini · September 8, 2026 · Disposition4.0K
- Andrea Albertini · September 8, 2026 · Tax Withholding603 @ $88.86
- William K. Daniel · June 12, 2026 · Grant2.2K
- Stanley M. Bergman · May 26, 2026 · Gift50
- Stanley M. Bergman · May 21, 2026 · Gift50
- Stanley M. Bergman · May 19, 2026 · Gift1.0K
- William K. Daniel · May 11, 2026 · Buy10.0K @ $69.19
Institutional Ownership
March 31, 2026
- Total shares held
- 111.20M
- Total value held
- $7.97B
- Institutional holders
- 551
- Unknown15.65M
- Unknown7.02M
- Unknown6.57M
- Unknown6.42M
- Unknown5.72M
- Unknown4.89M
- Unknown4.38M
- Unknown3.59M
- Unknown3.41M
- Unknown3.20M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Henry Schein Extends Credit Facility Amid Market Growth Projections
Henry Schein recently extended its credit facility, a move that supports its financial flexibility. This corporate action comes as the dental implants market is projected to grow from $12.79 billion in 2026 to $17.67 billion by 2031. The company also marked 25 years of its Henry Schein Cares initiative. These developments provide context for the stock's current position near its support level.
Henry Schein Extends Credit Facility Amid Market Growth Projections. Henry Schein recently extended its credit facility, a move that supports its financial flexibility. This corporate action comes as the dental implants market is projected to grow from $12.79 billion in 2026 to $17.67 billion by 2031. The company also marked 25 years of its Henry Schein Cares initiative. These developments provide context for the stock's current position near its support level.